These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 2437333
1. The response of poorly differentiated prostatic tumors to staining for prostate specific antigen and prostatic acid phosphatase: a comparative study. Keillor JS, Aterman K. J Urol; 1987 May; 137(5):894-6. PubMed ID: 2437333 [Abstract] [Full Text] [Related]
2. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications. Epstein JI, Eggleston JC. Hum Pathol; 1984 Sep; 15(9):853-9. PubMed ID: 6381284 [Abstract] [Full Text] [Related]
4. The ultrastructural localization of prostatic specific antigen and prostatic acid phosphatase in hyperplastic and neoplastic human prostates. Warhol MJ, Longtine JA. J Urol; 1985 Sep; 134(3):607-13. PubMed ID: 2411954 [Abstract] [Full Text] [Related]
11. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study. Ersev A, Ersev D, Turkeri L, Ilker Y, Simsek F, Kullu S, Akdas A. Prog Clin Biol Res; 1990 Dec; 357():129-34. PubMed ID: 1699237 [Abstract] [Full Text] [Related]
12. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen. Purnell DM, Heatfield BM, Trump BF. Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163 [Abstract] [Full Text] [Related]
13. Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma. Hammond ME, Sause WT, Martz KL, Pilepich MV, Asbell SO, Rubin P, Myers RP, Farrow GM. Cancer; 1989 Feb 01; 63(3):461-6. PubMed ID: 2463874 [Abstract] [Full Text] [Related]
14. [Immunohistochemical diagnosis of metastasizing prostatic carcinomas]. Friedmann W, Steffens J, Lobeck H. Onkologie; 1984 Dec 01; 7(6):337-41. PubMed ID: 6084838 [Abstract] [Full Text] [Related]
15. Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase. Svanholm H. Acta Pathol Microbiol Immunol Scand A; 1986 Jan 01; 94(1):7-12. PubMed ID: 2421532 [Abstract] [Full Text] [Related]
16. [Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen]. Mathieu MC, Caillaud JM. Bull Cancer; 1985 Jan 01; 72(5):405-13. PubMed ID: 2416371 [Abstract] [Full Text] [Related]
18. Prostate-specific antigen and prostate-specific acid phosphatase in neuroendocrine cells of prostate cancer. Cohen RJ, Glezerson G, Haffejee Z. Arch Pathol Lab Med; 1992 Jan 01; 116(1):65-6. PubMed ID: 1370878 [Abstract] [Full Text] [Related]
19. [Purification and enzyme immunoassay of tumor markers for prostate cancer: prostatic acid phosphatase, prostate-specific antigen and creatine kinase BB]. Morishita N, Minami Y, Ogawa S, Saito Y. Nihon Hinyokika Gakkai Zasshi; 1984 Mar 01; 75(3):404-13. PubMed ID: 6206268 [No Abstract] [Full Text] [Related]
20. Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate. Ellis DW, Leffers S, Davies JS, Ng AB. Am J Clin Pathol; 1984 Mar 01; 81(3):279-84. PubMed ID: 6199966 [Abstract] [Full Text] [Related] Page: [Next] [New Search]